Doxorubicin-Mediated Bone Loss in Breast Cancer Bone Metastases Is Driven by an Interplay between Oxidative Stress and Induction of TGFβ

Open Access

Peer-reviewed

Research Article

Tapasi Rana,

Affiliation Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯
Anwesa Chakrabarti,

Affiliation College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America
⨯
Michael Freeman,

Affiliations Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America, Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯
Swati Biswas

* E-mail: swati.biswas@vanderbilt.edu

Affiliations Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America, Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
⨯

Reader Comments (0)

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Antibody therapy
Is the Subject Area "Antibody therapy" applicable to this article?

Thanks for your feedback.
Osteoblasts
Is the Subject Area "Osteoblasts" applicable to this article?

Thanks for your feedback.
Osteoblast differentiation
Is the Subject Area "Osteoblast differentiation" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Osteoclasts
Is the Subject Area "Osteoclasts" applicable to this article?

Thanks for your feedback.
Bone marrow cells
Is the Subject Area "Bone marrow cells" applicable to this article?

Thanks for your feedback.